Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
52-week range
$1.64 – $2.71
50% from low
Borrow rate
12.83%
Hard to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | $0 | $544.9K | $16.9M | $16.4M | $20.5M | $20.2M | $30.3M |
| Cost of revenue | $854 | $38.3K | $4.7M | $5.0M | $5.5M | $7.3M | $14.4M |
| Gross profit | −$854 | $506.6K | $12.2M | $11.4M | $15.0M | $12.8M | $15.9M |
| Gross margin | — | 93.0% | 72.1% | 69.2% | 73.3% | 63.6% | 52.5% |
| R&D | $827.5K | $2.5M | $9.0M | $4.0M | $1.4M | $1.4M | $2.9M |
| Operating income | −$1.3M | −$5.0M | −$27.6M | −$19.0M | −$5.6M | −$7.0M | −$2.5M |
| EBITDA | −$1.3M | −$5.0M | −$24.0M | −$18.3M | $2.8M | −$2.9M | −$2.3M |
| Net income | −$1.3M | −$5.0M | −$26.6M | −$26.0M | $11.1M | −$3.8M | −$2.9M |
| Net margin | — | -914.0% | -157.3% | -158.2% | 54.2% | -18.7% | -9.5% |
| EPS (diluted) | -0.04 | -0.17 | -0.84 | -0.81 | 0.36 | -0.12 | -0.09 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $32M | $-0.04 | $-0.04–$-0.04 | 1 |
Forward consensus · source: Financial Modeling Prep
No one on the platform currently holds FORA.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 41,300 | $85.5K |
No one on the platform has traded FORA yet.
| $71M |
| — |
| LUNGPulmonx Corporation | $1.33 | +6.40% | $56M | — |
| NSRXNasus Pharma Ltd. | $3.45 | +3.92% | $30M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 3.0× sales vs its 4.4× historical median P/S.
Fair value ≈ $3.16 · price $2.17 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$FORA Outstanding article that hits the mark on FORA's current state. So if you want to refresh your FORA insights or learn about FORA from scratch, this is a must read. https://everyticker.com/quote/FORA/analysis/forian-s-2-17-take-private-price-why-the-market-is-pricing-perfect-execution-risk-nasdaq-fora
View on StockTwits ↗https://marketbeat.com/a/8658248/ $FORA VerticalScope Q1 Earnings Call Highlights
View on StockTwits ↗$FORA with FORA out, check CCLD in the same industry. Debt free, profitable, down lately.
View on StockTwits ↗$FORA merged with its parent, completing a $2.17 per share tender offer and will delist from Nasdaq.
View on StockTwits ↗$FORA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.11 down -175.00% YoY • Reported revenue of $6.85M down -2.91% YoY
View on StockTwits ↗$FORA / M. Wygod – Tender Offer Expires @ Midnight
View on StockTwits ↗https://www.marketbeat.com/earnings/reports/2026-5-12-verticalscope-holdings-inc-stock/ $FORA VerticalScope Earnings Transcript
View on StockTwits ↗2/3: Forian agreed to be acquired via tender offer at $2.17 per share in cash, with launch required within 10 business days of signing | View: A definitive cash offer sets a reference value… $FORA
View on StockTwits ↗$FORA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.06 down -700.00% YoY • Reported revenue of $7.96M up 36.99% YoY
View on StockTwits ↗$FORA is this crap ever going anywhere. Does it even have any hope?
View on StockTwits ↗$FORA Okay, time to show us how well you run the company and then up the offer before taking it private. Alternatively, embrace being public and allow the market to bring this much higher!
View on StockTwits ↗$FORA Current Stock Price: $2.10 Contracts to trade: $2.5 FORA Feb 20 2026 Call Entry: $0.09 Exit: $0.17 ROI: 86% Hold ~29 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗$FORA Up the private offer to $3+ and everyone will be happy!
View on StockTwits ↗$FORA is a telehealth or software company; requires user adoption and payer reimbursement.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.